WebbSharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers … Webb19 apr. 2024 · STSS SEC Filings - Sharps Technology Inc ... AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2. Sharps Technology, Inc. (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 82003F101 (CUSIP Number) April 13, 2024 (Date of Event. 2024-04-19: 8-K:
STSS Sharps Technology Inc. Analyst Estimates MarketWatch
Webb30 dec. 2024 · Sharps Technology Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. There are not analysts providing consensus earnings estimates for the current fiscal year. Sharps Technology Inc does not currently pay a dividend. WebbSharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers … ct070nl22-50nd-27d-cs
Sharps Technology Issues Update Letter to Shareholders from …
WebbSharps Technology, Inc. is a pre-revenue medical device company. It designs and patents various safety syringes and is seeking commercialization by manufacturing and … Webb24 mars 2024 · Sharps Technology, Inc. is a medical device company. The Company is designed and patented various safety syringes and is seeking commercialization by manufacturing and distributing its products. The Company provides Sharps Provensa, a line of smart safety syringes that offer solutions to global healthcare crises. WebbSharps Technology’s CEO is Robert Hayes, appointed in Sep 2024, he has a tenure of 1.6yrs. His total yearly compensation is US$369.5k, comprised of 84.8% salary and 15.2% bonuses, including company stock and options. He directly owns 0.5% of the company’s shares, worth US$75.3k. The average tenure of the management team and the board of ... ct0912